Assessment of normal erythropoiesis by flow cytometry: Important considerations for specimen preparation

International Journal of Laboratory Hematology

Volumn 36, Issue 2, 2014, Pages 184-196

  Wangen, J R ^a   Eidenschink Brodersen, L ^a   Stolk, T T ^b   Wells, D A ^a   Loken, M R ^a  

^a HEMATOLOGICS INC   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ammonium chloride lysis; Erythroid; Erythropoiesis; Flow cytometry; Glycophorin A; Hematopoiesis

Indexed keywords

ANTIGEN; CD235A ANTIGEN; CD34 ANTIGEN; CD36 ANTIGEN; CD45 ANTIGEN; FICOLL; MEMBRANE ANTIGEN; NUCLEIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL POPULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DENSITY GRADIENT; DYSPLASIA; ERYTHROID CELL; ERYTHROID DYSPLASIA; ERYTHROPOIESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYSIS; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULOCYTE;

AMMONIUM CHLORIDE LYSIS; ERYTHROID; ERYTHROPOIESIS; FLOW CYTOMETRY; GLYCOPHORIN A; HEMATOPOIESIS;

ANTIGENS, CD; BONE MARROW; BONE MARROW CELLS; CELL CYCLE; CELL DIFFERENTIATION; ERYTHROPOIESIS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; SPECIMEN HANDLING;

EID: 84896124196     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12151     Document Type: Article

References (25)

1. Della Porta MG, Francesco L, Del Vecchio L. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia. Cytometry B Clin Cytom 2011;80B:201-11.
2. Loken MR, van de Loosdrecht AA, Ogata K, Orfao A, Wells DA. Flow cytometry in myelodysplastic syndromes: report from a working conference. Leuk Res 2008;32:5-17.
3. Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, Haferlach T, Haase D, Kolb HJ, Krieger O, Loken MR, van de Loosdrecht A, Ogata K, Orfao A, Pfeilstocker M, Ruter B, Sperr WR, Stauder R, Wells DA. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res 2007;31:727-36.
4. van de Loosdrecht AA, Alhan C, Bene MC, Della Porta MG, Drager AM, Feuillard J, Font P, Germing U, Haase D, Homburg CH, Ireland R, Jansen JH, Kern W, Malcovati L, Te Marvelde JG, Mufti GJ, Ogata K, Orfao A, Ossenkoppele GJ, Porwit A, Preijers FW, Richards SJ, Schuurhuis GJ, Subira D, Valent P, van der Velden VH, Vyas P, Westra AH, de Witte TM, Wells DA, Loken MR, Westers TM. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica 2009;94:1124-34.
5. Westers TM, Ireland R, Kern W, Alhan C, Balleisen JS, Bettelheim P, Burbury K, Cullen M, Cutler JA, Della Porta MG, Drager AM, Feuillard J, Font P, Germing U, Haase D, Johansson U, Kordasti S, Loken MR, Malcovati L, te Marvelde JG, Matarraz S, Milne T, Moshaver B, Mufti GJ, Ogata K, Orfao A, Porwit A, Psarra K, Richards SJ, Subira D, Tindell V, Vallespi T, Valent P, van der Velden VH, de Witte TM, Wells DA, Zettl F, Bene MC, van de Loosdrecht AA. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia 2012;26:1730-41.
6. Kern W, Haferlach C, Schnittger S, Haferlach T. Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data. Cancer 2010;116:4549-63.
7. Malcovati L, Della Porta MG, Lunghi M, Pascutto C, Vanelli L, Travaglino E, Maffioli M, Bernasconi P, Lazzarino M, Invernizzi R, Cazzola M. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia 2005;19:776-83.
8. Ogata K, Nakamura K, Yokose N, Tamura H, Tachibana M, Taniguchi O, Iwakiri R, Hayashi T, Sakamaki H, Murai Y, Tohyama K, Tomoyasu S, Nonaka Y, Mori M, Dan K, Yoshida Y. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 2002;100:3887-96.
9. Stetler-Stevenson M, Arthur DC, Jabbour N, Xie XY, Molldrem J, Barrett AJ, Venzon D, Rick ME. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 2001;98:979-87.
10. van de Loosdrecht AA, Westers TM, Westra AH, Drager AM, van der Velden VH, Ossenkoppele GJ. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood 2008;111:1067-77.
11. Matarraz S, Lopez A, Barrena S, Fernandez C, Jensen E, Flores-Montero J, Rasillo A, Sayagues JM, Sanchez ML, Barcena P, Hernandez-Rivas JM, Salvador C, Fernandez-Mosteirin N, Giralt M, Perdiguer L, Laranjeira P, Paiva A, Orfao A. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients. Cytometry B Clin Cytom 2010;78:154-68.
12. Scott BL, Wells DA, Loken MR, Myerson D, Leisenring WM, Deeg HJ. Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome. Blood 2008;112:2681-6.
13. Stachurski D, Smith BR, Pozdnyakova O, Andersen M, Xiao Z, Raza A, Woda BA, Wang SA. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls. Leuk Res 2008;32:215-24.
14. Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, Deeg HJ. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003;102:394-403.
15. Della Porta MG, Malcovati L, Invernizzi R, Travaglino E, Pascutto C, Maffioli M, Galli A, Boggi S, Pietra D, Vanelli L, Marseglia C, Levi S, Arosio P, Lazzarino M, Cazzola M. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia 2006;20:549-55.
16. Lorand-Metze I, Ribeiro E, Lima CS, Batista LS, Metze K. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders. Leuk Res 2007;31:147-55.
17. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood 1987;69:255-63.
18. Chernyshev AV, Tarasov PA, Semianov KA, Nekrasov VM, Hoekstra AG, Maltsev VP. Erythrocyte lysis in isotonic solution of ammonium chloride: theoretical modeling and experimental verification. J Theor Biol 2008;251:93-107.
19. Shvalov AN, Soini JT, Chernyshev AV, Tarasov PA, Soini E, Maltsev VP. Light-scattering properties of individual erythrocytes. Appl Opt 1999;38:230-5.
20. Jacobs MH, Stewart DR. The role of carbonic anhydrase in certain ionic exchanges involving the erythrocyte. J Gen Physiol 1942;25:539-52.
21. Allan RW, Nsari-Lari MA, Jordan S. DRAQ5-based, no-lyse, no-wash bone marrow aspirate evaluation by flow cytometry. Am J Clin Pathol 2008;129:706-13.
22. Owens M, Loken M. Flow Cytometry Principles for Clinical Laboratory Practice: Quality Assurance for Quantitative Immunophenotyping. NewYork, NY: Wiley-Liss, 1995.
23. Terstappen LW, Loken MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol 1990;2:229-40.
24. Matarraz S, Fernandez C, Albors M, Teodosio C, Lopez A, Jara-Acevedo M, Cervero C, Caballero G, Gutierrez O, Orfao A. Cell-cycle distribution of different cell compartments in normal versus reactive bone marrow: a frame of reference for the study of dysplastic hematopoiesis. Cytometry B Clin Cytom 2011;80B:354-61.
25. Machherndl-Spandl S, Suessner S, Danzer M, Proell J, Gabriel C, Lauf J, Sylie R, Klein HU, Béné MC, Weltermann A, Bettelheim P. Molecular pathways of early CD105-positive erythroid cells as compared with CD34-positive common precursor cells by flow cytometric cell-sorting and gene expression profiling. Blood Cancer J 2013;3:e100.